Xiaoyan Hui

3.5k total citations · 1 hit paper
61 papers, 2.5k citations indexed

About

Xiaoyan Hui is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Xiaoyan Hui has authored 61 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 30 papers in Physiology and 25 papers in Molecular Biology. Recurrent topics in Xiaoyan Hui's work include Adipose Tissue and Metabolism (29 papers), Adipokines, Inflammation, and Metabolic Diseases (27 papers) and Cardiovascular Disease and Adiposity (9 papers). Xiaoyan Hui is often cited by papers focused on Adipose Tissue and Metabolism (29 papers), Adipokines, Inflammation, and Metabolic Diseases (27 papers) and Cardiovascular Disease and Adiposity (9 papers). Xiaoyan Hui collaborates with scholars based in China, Hong Kong and New Zealand. Xiaoyan Hui's co-authors include Aimin Xu, Yu Wang, Tianshi Feng, Karen S.L. Lam, Paul M. Vanhoutte, Yong Pan, Ping Gu, Karen SL Lam, Donghai Wu and Dewei Ye and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xiaoyan Hui

58 papers receiving 2.5k citations

Hit Papers

Adipocyte-secreted exosomal microRNA-34a inhibits M2 macr... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyan Hui China 24 1.2k 931 911 376 313 61 2.5k
Aiwei Yao‐Borengasser United States 23 1.2k 0.9× 1.3k 1.4× 1.3k 1.4× 384 1.0× 223 0.7× 32 3.0k
Carolina E. Hagberg Sweden 16 912 0.7× 749 0.8× 555 0.6× 332 0.9× 250 0.8× 27 2.1k
Antje Garten Germany 24 1.1k 0.8× 1.0k 1.1× 1.3k 1.4× 205 0.5× 265 0.8× 67 3.5k
Ricardo Rodríguez‐Calvo Spain 28 1.3k 1.0× 702 0.8× 519 0.6× 325 0.9× 232 0.7× 64 2.3k
Yingfeng Deng United States 26 1.1k 0.9× 769 0.8× 811 0.9× 268 0.7× 189 0.6× 43 2.5k
Tamara L. Allen Australia 15 856 0.7× 1.0k 1.1× 653 0.7× 175 0.5× 131 0.4× 19 2.0k
Zhimin Chen China 21 684 0.5× 526 0.6× 570 0.6× 213 0.6× 169 0.5× 45 1.7k
Jaap G. Neels France 24 1.1k 0.9× 1.3k 1.4× 1.7k 1.9× 373 1.0× 426 1.4× 44 3.7k
Kae Won Cho United States 27 684 0.5× 732 0.8× 817 0.9× 176 0.5× 170 0.5× 54 2.2k
Robert E. McGehee United States 27 1.6k 1.3× 1.5k 1.6× 1.3k 1.5× 387 1.0× 248 0.8× 48 3.6k

Countries citing papers authored by Xiaoyan Hui

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Hui more than expected).

Fields of papers citing papers by Xiaoyan Hui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Hui. The network helps show where Xiaoyan Hui may publish in the future.

Co-authorship network of co-authors of Xiaoyan Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Hui. A scholar is included among the top collaborators of Xiaoyan Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Hui. Xiaoyan Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Xinya, Jing Zhang, Xin Liu, et al.. (2025). Targeting CD37 promotes macrophage-dependent phagocytosis of multiple cancer cell types and facilitates tumor clearance in mice. Nature Communications. 16(1). 6610–6610. 2 indexed citations
2.
Cheng, Ying, Qing Liu, Qiaoyun Long, et al.. (2025). LETM-domain containing 1 (LETMD1) protects against obesity via enhancing UCP1-independent energy expenditure in human beige adipocytes. Theranostics. 15(5). 1914–1929. 1 indexed citations
4.
Xu, Xiaofan, Xiaomu Li, Gloria Hoi‐Yee Li, et al.. (2024). MDM2 induces pro-inflammatory and glycolytic responses in M1 macrophages by integrating iNOS-nitric oxide and HIF-1α pathways in mice. Nature Communications. 15(1). 8624–8624. 46 indexed citations
5.
Zhang, Haowei, Wanyu Hu, Liuling Xiao, et al.. (2024). Adipose stem cells control obesity-induced T cell infiltration into adipose tissue. Cell Reports. 43(3). 113963–113963. 14 indexed citations
6.
Zhang, Yuping, Jingwen Wu, Xiaoyan Hui, Peipei Zhang, & Xue Fang. (2024). Knowledge, attitude, and practice toward tuberculosis prevention and management among household contacts in Suzhou Hospital, Jiangsu province, China. Frontiers in Public Health. 12. 1249971–1249971. 1 indexed citations
7.
Gu, Ping, Kai Ding, Lei Lu, et al.. (2023). Compromised browning in white adipose tissue of ageing people. European Journal of Endocrinology. 188(2). 226–235. 4 indexed citations
8.
Feng, Tianshi, Xuemei Zhao, Ping Gu, et al.. (2022). Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2. Nature Communications. 13(1). 5208–5208. 104 indexed citations
9.
Feng, Tianshi, Leigang Jin, Éric Honoré, et al.. (2022). Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature Communications. 13(1). 7838–7838. 23 indexed citations
10.
Mao, Liufeng, Lijie Peng, Xiaomei Ren, et al.. (2022). Discovery of JND003 as a New Selective Estrogen-Related Receptor α Agonist Alleviating Nonalcoholic Fatty Liver Disease and Insulin Resistance. PubMed. 2(3). 282–296. 7 indexed citations
11.
Wang, Lin, Zhuohao Liu, Dewei Ye, et al.. (2022). Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation. Advanced Science. 9(20). e2200742–e2200742. 29 indexed citations
12.
Gu, Ping, Xiaoyan Hui, Qiantao Zheng, et al.. (2021). Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome–dependent interleukin-1β production. Science Advances. 7(50). eabl4024–eabl4024. 39 indexed citations
13.
Pan, Yong, Xiaoyan Hui, Ruby L.C. Hoo, et al.. (2019). Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation. Journal of Clinical Investigation. 129(2). 834–849. 364 indexed citations breakdown →
14.
Li, Huating, Guangyu Wu, Qichen Fang, et al.. (2018). Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat. Nature Communications. 9(1). 272–272. 136 indexed citations
15.
Hui, Xiaoyan, Mingliang Zhang, Ping Gu, et al.. (2017). Adipocyte SIRT 1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue. EMBO Reports. 18(4). 645–657. 74 indexed citations
16.
Nie, Baoming, Tao Nie, Xiaoyan Hui, et al.. (2017). Brown Adipogenic Reprogramming Induced by a Small Molecule. Cell Reports. 18(3). 624–635. 53 indexed citations
17.
Hui, Xiaoyan, Tianshi Feng, Qing Liu, Yuan Gao, & Aimin Xu. (2016). The FGF21–adiponectin axis in controlling energy and vascular homeostasis. Journal of Molecular Cell Biology. 8(2). 110–119. 78 indexed citations
19.
Hoo, Ruby L.C., et al.. (2012). Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. Journal of Hepatology. 58(2). 358–364. 70 indexed citations
20.
Chen, Cheng, et al.. (2011). Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes. Journal of Biological Chemistry. 286(40). 34533–34541. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026